Tilaknagar Industries is navigating a transformative period as it integrates the Imperial Blue whisky business while managing record-breaking sales volumes. Investors will be focused on the company's ability to balance margin-pressuring input costs with the operational efficiencies gained from its expanded in-house bottling capacity.
| Results date | July 27, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 949 Cr |
| Previous quarter PAT | Rs. (15) Cr |
| Previous quarter EBITDA margin | 16.3% |
| Net debt (latest quarter) | Rs. 1,934 Cr |
| Market cap | Rs. 10,919.77 Cr |
| CMP | Rs. 441.25 |
The board meeting is scheduled for July 27, 2026, to consider the Q1 FY27 unaudited financial results.
The company enters Q1 FY27 with significant volume momentum, reporting record sales of 3.4 million cases in June 2026 and over 3 million cases in May 2026. While demand remains strong, management faces a material input cost headwind from a 15–20% surge in glass bottle prices that emerged during the quarter. To offset these pressures, the firm is leveraging the recent 6x capacity expansion at the Prag Distillery, which is expected to yield annual bottling savings of Rs. 10 crore. Furthermore, the Karnataka government's implementation of a Rs. 20 MRP reduction on 180ml packs of Imperial Blue and Mansion House is expected to drive volume growth, consistent with historical precedents of similar price cuts. The upcoming call will likely focus on the TSMA expense run-rate, which was approximately Rs. 14 crore per month in Q4 FY26, and the pace of deleveraging toward the Rs. 1,700 crore net debt target set for March 2027.
Performance vs Guidance Tracking
IB Integration and Operational Focus
Risks and Headwinds to Monitor
As of the start of Q1 FY27, Tilaknagar Industries has exited the Transition Services and Manufacturing Agreement (TSMA) for approximately 75% of the Imperial Blue business. The company aims to complete the exit for the remaining states no later than Q4 FY27.
The expansion at the Prag Distillery increased capacity from 6 lakh to 36 lakh cases per annum. This investment is expected to generate annual savings of Rs. 10 crore in bottling costs.
Finance costs rose to Rs. 113 crore in FY26 compared to Rs. 12 crore in FY25, primarily due to debt taken on for the Imperial Blue acquisition. In Q4 FY26 alone, finance costs reached Rs. 69 crore.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now